Home/Filings/4/0000911916-16-000634
4//SEC Filing

ZIMMER BIOMET HOLDINGS, INC. 4

Accession 0000911916-16-000634

$ZBHCIK 0001136869operating

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 3:19 PM ET

Size

17.0 KB

Accession

0000911916-16-000634

Insider Transaction Report

Form 4
Period: 2016-08-01
Nolan David A. Jr.
Group President
Transactions
  • Sale

    Common Stock

    2016-08-01$130.73/sh14,292$1,868,36314,799 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2016-08-014,1384,137 total
    Exercise: $94.34Exp: 2024-03-17Common Stock (4,138 underlying)
  • Exercise/Conversion

    Common Stock

    2016-08-01$73.15/sh+14,292$1,045,46029,091 total
  • Exercise/Conversion

    Common Stock

    2016-08-01$94.34/sh+4,138$390,37918,937 total
  • Sale

    Common Stock

    2016-08-01$130.85/sh6,825$893,0297,974 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2016-08-0114,2924,763 total
    Exercise: $73.15Exp: 2023-03-18Common Stock (14,292 underlying)
  • Sale

    Common Stock

    2016-08-01$130.77/sh4,138$541,13914,799 total
Footnotes (6)
  • [F1]Includes 59 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between May 2, 2016 and June 30, 2016, 37 shares purchased between April 29, 2016 and July 29, 2016 under the dividend reinvestment plan for the Company's common stock, and 20 shares acquired between February 29, 2016 and June 30, 2016 through dividend reinvestment in Mr. Nolan's IRA.
  • [F2]Represents the sale of 14,292 shares in multiple transactions, ranging in price from $130.58 to $130.94 per share, resulting in a weighted average sale price of $130.7279. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F3]Represents the sale of 4,138 shares in multiple transactions, ranging in price from $130.68 to $130.90 per share, resulting in a weighted average sale price of $130.7731. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F4]Represents the sale of 6,825 shares in multiple transactions, ranging in price from $130.775 to $130.895 per share, resulting in a weighted average sale price of $130.8468. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F5]4,764 of the options vested on each of March 18, 2014, 2015 and 2016; the remaining 4,763 of the options are scheduled to vest on March 18, 2017.
  • [F6]2,069 of the options vested on each of March 17, 2015 and 2016; 2,069 of the options are scheduled to vest on March 17, 2017; and the remaining 2,068 of the options are scheduled to vest on March 17, 2018.

Issuer

ZIMMER BIOMET HOLDINGS, INC.

CIK 0001136869

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001136869

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 3:19 PM ET
Size
17.0 KB